-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Scientific Workshop on What ‘Omics Are Telling Us About Molecular Mechanisms in Sickle Cell Disease - Scientific Workshops @ ASH

Wednesday, December 2, 2020

Wednesday | Thursday | Friday | top

7:00 AM-7:05 AM

Scientific Workshop on Infectious Disease and Coagulation - Opening Remarks
Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies - Opening Remarks
Scientific Workshop on Myeloid Development - Opening Remarks

7:05 AM-7:45 AM

Stem Cells

7:05 AM-8:20 AM

Immune Engaging Molecules in the Management of Lymphoid Malignancies

7:05 AM-8:30 AM

The Immunohemostatic Response to Infection

7:45 AM-8:25 AM

Hematologic Malignancies

8:20 AM-9:55 AM

Engineered Immune Cells in the Management of Lymphoid Malignancies

8:35 AM-9:15 AM

Transcription Factors and Epigenetics

8:35 AM-9:35 AM

Prevention and Monitoring

9:15 AM-9:55 AM

Signaling and Development

9:35 AM-9:50 AM

Full Panel Discussion

9:50 AM-10:00 AM

Scientific Workshop on Infectious Disease and Coagulation - Closing Remarks

9:55 AM-10:00 AM

Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies - Closing Remarks
Scientific Workshop on Myeloid Development - Closing Remarks

Thursday, December 3, 2020

Wednesday | Thursday | Friday | top

7:00 AM-7:02 AM

Scientific Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma - Opening Remarks

7:00 AM-7:05 AM

Scientific Workshop on Interplay Between Coagulation and Malignancy - Opening Remarks

7:02 AM-7:42 AM

Integrating MRD into Clinical Trial Design and Clinical Practice

7:05 AM-7:29 AM

MicroRNA and Role in Cancer Associated Thrombosis

7:29 AM-8:17 AM

Interplay Between the Hematologic System and Solid Tumor Progression

7:42 AM-8:22 AM

The Molecular and Immunobiology of Disease Evolution and Progression in Multiple Myeloma

8:17 AM-8:55 AM

Modeling Predictors and Outcomes in Myeloproliferative Neoplasms and Thrombosis

8:32 AM-9:12 AM

Adaption of Next Generation Sequencing, Next Generation Flow Cytometry, and CyTOF: Diverse Ways of Detection

8:55 AM-9:56 AM

Late-Breaking Research Presentations

9:12 AM-9:57 AM

CAR-T and Other Cellular Therapy for Mutiple Myeloma

9:56 AM-10:00 AM

Scientific Workshop on Interplay Between Coagulation and Malignancy - Closing Remarks

9:57 AM-10:00 AM

Scientific Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma - Closing Remarks

2:00 PM-2:02 PM

Scientific Workshop on Hematology & Aging: Exploring Biomarkers, CHIP, CAR-T and Clotting - Opening Remarks

2:00 PM-2:05 PM

Scientific Workshop on Epidemiology: Disparities in Hematologic Diseases: Risk, Outcomes and Care - Opening Remarks
Scientific Workshop on Translational Molecular Diagnostics in Hematology - Opening Remarks

2:02 PM-2:45 PM

Thrombosis + Aging

2:05 PM-2:45 PM

Overcoming Challenges in Delivering Diagnostic Genomics in Hematology

2:05 PM-3:30 PM

Disparities in Malignant Hematology

2:45 PM-3:17 PM

CAR-T

2:45 PM-3:20 PM

Novel Diagnostic Genomic Tools and Technologies

3:22 PM-4:05 PM

Biomarkers of Aging

3:30 PM-4:25 PM

Variant Curation: How Should We Interpret What We Find?

3:30 PM-4:30 PM

Disparities in Benign Hematology

4:05 PM-4:58 PM

CHIPing Away at the Hematopoietic Stem Cell Niche

4:25 PM-4:55 PM

Molecular Tumor Board

4:30 PM-4:35 PM

Scientific Workshop on Epidemiology: Disparities in Hematologic Diseases: Risk, Outcomes and Care - Closing Remarks

4:55 PM-5:00 PM

Scientific Workshop on Translational Molecular Diagnostics in Hematology - Closing Remarks

4:58 PM-5:00 PM

Scientific Workshop on Hematology & Aging: Exploring Biomarkers, CHIP, CAR-T and Clotting - Closing Remarks

Friday, December 4, 2020

Wednesday | Thursday | Friday | top

7:00 AM-7:05 AM

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure - Opening Remarks
Scientific Workshop on Hematology and Pregnancy - Opening Remarks
Scientific Workshop on What ‘Omics Are Telling Us About Molecular Mechanisms in Sickle Cell Disease - Opening Remarks

7:05 AM-7:52 AM

Germline Predisposition Syndrome Modeling

7:05 AM-8:05 AM

Thrombosis and Bleeding in Pregnancy

7:05 AM-8:10 AM

Omics Approaches to Erythrocyte Biology in Sickle Cell Disease

7:52 AM-8:32 AM

SAMD9/SAMD9L Syndrome: Clinical and Biological Aspects

8:05 AM-8:50 AM

Interplay of Pregnancy and Sickle Cell Disease

8:15 AM-9:05 AM

Exploring the ‘Omics of Cardiovascular and Renal Sequelae of Sickle Cell Disease

8:32 AM-9:05 AM

Socioeconomic Considerations and Quality of Life Issues in Patients with Germline Predisposition

8:50 AM-9:50 AM

Complement Activation and Thrombotic Microangiopathies in Pregnancy

9:05 AM-9:52 AM

New Insights Into Germline Predisposition

9:10 AM-9:55 AM

Mechanistic Insights into Neurological Disease and Pain

9:50 AM-10:00 AM

Scientific Workshop on Hematology and Pregnancy - Closing Remarks

9:52 AM-10:00 AM

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure - Closing Remarks

9:55 AM-10:00 AM

Scientific Workshop on What ‘Omics Are Telling Us About Molecular Mechanisms in Sickle Cell Disease - Closing Remarks